To facilitate
communication between stakeholders involved in prostate cancer care.

2.9 millions

new cases of prostate cancer expected in 2040.

50%

of patients treated with hormone therapy

+20%

of risk of death from cardiovascular disease under hormone therapy

+20 à 30%

of increased risk of cardiovascular events under hormone therapy